CG
LABD icon

Cutler Group’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Cutler Group’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,910
Closed -$157K – 3011
2023
Q4 		$157K Buy
1,910
+1,820
+2,022% +$354K 0.01% 855
2023
Q3 		$1K Sell
90
-130
-59% -$21.1K ﹤0.01% 3557
2023
Q2 		$13K Sell
220
-1,470
-87% -$220K ﹤0.01% 2104
2023
Q1 		$41K Sell
1,690
-1,990
-54% -$338K ﹤0.01% 1469
2022
Q4 		$61K Buy
3,680
+3,000
+441% +$615K 0.01% 1454
2022
Q3 		$29K Buy
680
+290
+74% +$67.4K ﹤0.01% 2328
2022
Q2 		$33K Sell
390
-2,580
-87% -$1.29M ﹤0.01% 2261
2022
Q1 		$205K Buy
2,970
+2,020
+213% +$792K 0.01% 1169
2021
Q4 		$28K Sell
950
-1,030
-52% -$237K ﹤0.01% 2864
2021
Q3 		$71K Buy
1,980
+900
+83% +$191K ﹤0.01% 2209
2021
Q2 		$81K Sell
1,080
-1,310
-55% -$294K ﹤0.01% 2058
2021
Q1 		$66K Buy
2,390
+1,910
+398% +$370K ﹤0.01% 2107
2020
Q4 		$64K Sell
480
-1,150
-71% -$439K ﹤0.01% 1821
2020
Q3 		$223K Buy
1,630
+1,474
+945% +$951K 0.01% 867
2020
Q2 		$286K Buy
156
+4
+3% +$5.02K 0.02% 688
2020
Q1 		$164K Sell
152
-310
-67% -$885K 0.01% 1073
2019
Q4 		$588K Buy
462
+92
+25% +$327K 0.04% 391
2019
Q3 		$248K Sell
370
-9
-2% -$37.1K 0.02% 605
2019
Q2 		$386K Buy
379
+236
+165% +$994K 0.04% 413
2019
Q1 		$245K Buy
143
+122
+581% +$591K 0.03% 564
2018
Q4 		$66K Sell
21
-18
-46% -$132K 0.01% 1315
2018
Q3 		$138K Buy
39
+19
+95% +$91.7K 0.01% 1029
2018
Q2 		$136K Buy
+20
New +$121K 0.01% 957
2017
Q4 		– Sell
-3
Closed -$7K – 5431
2017
Q3 		$7K Buy
3
+1
+50% +$12.1K ﹤0.01% 4106
2017
Q2 		$7K Sell
2
-9
-82% -$173K ﹤0.01% 4527
2017
Q1 		$19K Buy
11
+6
+120% +$148K ﹤0.01% 3375
2016
Q4 		$15K Buy
5
+4
+400% +$154K ﹤0.01% 3755
2016
Q3 		$19K Sell
1
-42
-98% -$1.96M ﹤0.01% 3466
2016
Q2 		$1.3M Buy
43
+23
+115% +$1.85M 0.07% 226
2016
Q1 		$982K Buy
20
+13
+186% +$1.66M 0.06% 266
2015
Q4 		$331K Buy
+7
New +$535K 0.02% 825

Other funds holding LABD

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ASM
AI-Squared Management Hong Kong $137M AUM 102.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

Cutler Group's LABD Position: Q1 2024 in Review

Cutler Group sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2024, closing a stake of 10 shares — an estimated $834 sold.

Cutler Group first reported a position in LABD in Q1 2016 and held it in 23 quarters. The position peaked at $405K in Q2 2021. 21 funds tracked by Wall St. Rank hold LABD as of Q1 2024.

  • Cutler Group reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 10 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2024, an estimated $834.
  • Cutler Group first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2016 and held it in 23 quarters.
  • Cutler Group's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $405K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.